Z Geburtshilfe Neonatol 2022; 226(06): 422-423
DOI: 10.1055/a-1924-0246
Perinatalmedizin in Bildern

Uterocutaneous Fistula Secondary to an Uncomplicated Repetitive Cesarean Section

Neset Gumusburun
1   Department of Obstetrics and Gynecology, Kilis State Hospital, Kilis, Turkey
,
Huseyin Kurt
1   Department of Obstetrics and Gynecology, Kilis State Hospital, Kilis, Turkey
,
Ayhan Aksoy
1   Department of Obstetrics and Gynecology, Kilis State Hospital, Kilis, Turkey
,
Erdem Fadiloglu
2   Division of Perinatal Medicine, Department of Obstetrics and Gynecology, Cengiz Gokcek Women's Health and Child Hospital
› Author Affiliations

Case Presentation

A 34-year-old patient who had undergone cesarean section (C/S) one week ago was admitted to our institution with a complaint of serous drainage from her incision. Her medical history was uneventful except for 3 previous C/S surgeries. She had her last operation at another institution with no complications, according to her medical records. We hospitalized the patient with a diagnosis of wound infection and administered an antibiotic regimen consisting of cephalosporin and metronidazole for ten days. After this treatment, we were able to discharge the patient without any complaints.

However, one month after discharge, she was readmitted complaining of sero-hemorrhagic drainage from a pinpoint on her scar. The initial examination raised suspicion of utero-cutaneous fistula. Her physical and laboratory findings were unremarkable. An attempt to perform fistulography with a probe inserted into the fistula duct failed due to the impossibility of guiding the catheter properly. Therefore, we scheduled a computed tomography scan, which eventually confirmed the clinical diagnosis ([Fig. 1]). After discussing the possible treatment modalities including hysterectomy, the patient opted for a uterus-preserving procedure. We then performed an explorative laparotomy, fistulectomy, and metroplasty ([Fig. 2]). The patient was discharged four days after surgery with a prophylactic antibiotic regimen. At a follow-up visit two months later, she had no complaints.

Zoom Image
Fig. 1 Abdominal computed tomography showing the uterocutaneous fistula (arrows).
Zoom Image
Fig. 2 Intraoperative picture of the uterus after excision of the fistula tract.


Publication History

Article published online:
14 September 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Arrowsmith SD, Ruminjo J, Landry EG. Current practices in treatment of female genital fistula: a cross sectional study. BMC pregnancy and childbirth 2010; 10: 1-11
  • 2 Arteaga JDR, Murillo ANV, Trejo MCH. Utero-cutaneous fistula: a case report and literature review. Ginecologia y obstetricia de Mexico 2012; 80: 95-98
  • 3 Ballin M. Menstrual fistulae of postoperative and endometrial origin. Surg Gynecol Obstet 1928; 46: 525
  • 4 Taingson MC, Adze JA, Bature SB. et al. Utero-cutaneous fistula following cesarean section. Nigerian Journal of Surgical Research 2016; 17: 58
  • 5 Maddah G, Fattahi AS, Rahnama A. et al. Uterocutaneous fistula following cesarean section: successful management of a case. Iranian journal of medical sciences 2016; 41: 157
  • 6 Anderson KB, Søgaard-Andersen E, Aleksyniene R. et al. Spontaneous utero-cutaneous fistula between a benign uterine leiomyoma and abdominal skin: A case report. Case Reports in Women’s Health 2021; 29: e00282
  • 7 Athanasias P, Krishna A, Karoshi M. et al. Uterocutaneous fistula following classical caesarean delivery for placenta percreta with intentional retention of the placenta. Journal of Obstetrics and Gynaecology 2013; 33: 906-907
  • 8 Gupta S, Shukla V, Varma D. et al. Uterocutaneous fistula. Postgraduate medical journal 1993; 69: 822-823
  • 9 Thakur M, Rathore SS, Jindal A. et al. Uterocutaneous fistula following B-Lynch suture for primary postpartum haemorrhage. Case Reports 2018; 2018: bcr-2017-223518
  • 10 Seyhan A, Ata B, Sidal B. et al. Medical treatment of uterocutaneous fistula with gonadotropin-releasing hormone agonist administration. Obstetrics & Gynecology 2008; 111: 526-528